Checked by automated content guards before publishing. This article has not been reviewed by a licensed clinician.
A recall is one of the few events in a cash-pay service line that cannot wait for the next staff meeting. When a pharmacy that compounds recalls a preparation, the practice that prescribed it has to answer three questions quickly: which of our patients received it, how do we reach them, and what do we write down. Practices that settle those answers before launch handle a recall in hours. Practices that do not can spend days rebuilding a list from scattered charts. This guide sets out a plan. It is general information, not legal advice, and it names no products.
What a recall is
FDA describes a recall as an action a firm takes to remove a product from the market. A recall can happen on the firm's own initiative, at FDA's request, or by FDA order under statutory authority. FDA's recall regulations sit in 21 CFR Part 7, and they sort recalls into three classes by the health hazard involved:
- Class I. A reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death.
- Class II. Use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious consequences is remote.
- Class III. Use of or exposure to the product is not likely to cause adverse health consequences.
FDA also uses the term market withdrawal for a minor violation that would not be subject to FDA legal action. The class tells the practice how urgent the response is. It does not change the steps.
Drugs a pharmacy compounds are not FDA-approved, and FDA does not review them before they are marketed. That makes the practice's own records, and the pharmacy's notice, the main way a problem reaches the patient.
How the practice finds out
Do not rely on a single channel. A workable setup has at least three:
- The dispensing pharmacy. Your pharmacy agreement should say how and how fast the pharmacy notifies prescribers of a recall, and to which named contact at the practice. Ask for this in writing before the first order.
- FDA's public listings. FDA posts recalls, market withdrawals and safety alerts, and keeps a separate page of compounding inspections, recalls and other actions. Assign one person to check them on a set schedule.
- Your own staff. A patient call about an unusual container, label, or appearance is sometimes the first signal. Front desk scripts should route those calls to the clinical lead the same day.
Name one recall owner and one backup. Put both names in the service line file.
Find the affected patients from your own records
The question is always narrower than "who is on this therapy". A recall usually names a preparation, a strength, and one or more lot numbers or dates. To match against that, the practice needs to have recorded, for every compounded prescription:
- the patient, the prescription date, and the prescriber;
- the dispensing pharmacy;
- the lot number and beyond use date the pharmacy reported, where it reported them;
- where the preparation went: shipped to the patient, picked up, or delivered to the office.
If your charting template does not capture the pharmacy and the lot, add those fields now. Rebuilding them during a recall means calling the pharmacy for its dispensing records, which costs the time a Class I recall does not allow.
Run the search, save the result as a dated list, and have a second person check it against the pharmacy's own list of shipments to the practice's patients.
Reach the patients
- Who calls. A licensed clinician, or staff working from an approved script, contacts each patient on the list. The script says what was recalled, what the patient should do with any remaining supply as the recall notice instructs, and who to call with questions.
- What staff do not do. Staff do not offer clinical advice beyond the script, do not speculate about cause, and route any patient who reports a problem to the prescriber the same day.
- How it is logged. Each attempt is recorded: date, method, outcome, and the staff member. Set a rule for how many attempts are made before a letter goes out.
- Office stock. If recalled units are in the office, quarantine them, label them as recalled, and follow the pharmacy's return or disposal instructions. Record the count.
Patients may use any licensed pharmacy, so the practice's list covers only the prescriptions it wrote and the pharmacies it knows about. Say so in the file.
Report and record
When a patient reports a problem that may be linked to a recalled preparation, the prescriber decides on any clinical follow up. Separately, the practice reports the event to the dispensing pharmacy and can file a voluntary report with FDA MedWatch. Keep a copy of every report.
Close the recall with a short memo: the notice received, the date, the patient list, contact results, units quarantined or returned, reports filed, and who signed off. File it with the service line records.
Rehearse before you need it
Run a mock recall before launch and once a year after. Pick a real lot from your records, time how long it takes to produce the patient list, and walk through the first three calls with the script. The first mock recall usually finds a missing field in the charting template. That is the point of running it.
How SiriusRx helps
Sirius Peptides, by SiriusRx, gives your practice a secure workspace and managed ordering. Optional add-ons include templates and a quick-start guide.
General information, not legal advice.
Sources
- U.S. Food and Drug Administration (FDA), Recalls Background and Definitions.
- 21 CFR Part 7, Enforcement Policy (recalls): https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-7.
- U.S. Food and Drug Administration (FDA), Recalls, Market Withdrawals, and Safety Alerts.
- U.S. Food and Drug Administration (FDA), Compounding: Inspections, Recalls, and other Actions.
- U.S. Food and Drug Administration (FDA), Compounding and the FDA: Questions and Answers.
- U.S. Food and Drug Administration (FDA) MedWatch, the FDA safety information and adverse event reporting program.

